相关实验视频

Updated: Jul 16, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

GSK-3β激活介导2型糖尿病中阿波利波蛋白E4相关认知障碍:一个多中心,横截面研究

Yang Gao^1,2, Haitao Yu³, Yanchao Liu⁴

¹Department of Pathophysiology, School of Basic Medicine, Ministry of Education Key Laboratory for Neurological Disorders, Hubei Key Laboratory for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Journal of diabetes

|September 13, 2023

概括

在2型糖尿病中,ApoE ε4基因和高的GSK-3β活性加剧了认知衰退. GSK-3β上调调节会调节这种效果,这表明GSK-3β抑制剂可能会保护这些患者的认知能力.

科学领域:

神经科学是一个神经科学.
内分泌学在内分泌学.
遗传学是一个遗传学.

背景情况:

2型糖尿病 (T2DM) 与认知能力下降和阿尔茨海默病有关.
糖原合成酶激酶-3β (GSK-3β) 激活和阿波利波蛋白E (ApoE) ε4基因型都与认知障碍相关.
在T2DM中,ApoE ε4,GSK-3β和认知障碍之间的特定关系尚不清楚.

研究的目的:

调查ApoE基因型,GSK-3β活性和T2DM患者的认知功能之间的关联.
阐明GSK-3β在ApoE ε4与T2DM认知障碍之间的关系中的调解作用.

主要方法:

从中国武汉的五个医疗中心招募了1139名T2DM患者.
测量了ApoE基因型和血小板GSK-3β水平.
使用迷你心理状态检查 (MMSE) 评估认知功能,并使用回归和调解效应分析分析数据.

主要成果:

与ApoE ε3载体相比,患有ApoE ε4的T2DM患者表现出较差的认知功能和较高的血小板GSK-3β活性.
升高的GSK-3β活性与糖尿病持续时间,HbA1c和葡萄糖水平正相关.
发现GSK-3β活性会调解由ApoE ε4基因型引起的认知障碍恶化.

结论:

上调的GSK-3β活性调解了T2DM患者的ApoE ε4增强认知障碍.
GSK-3β抑制剂在T2DM患者的认知功能保存方面显示出有前途,特别是那些具有ApoE ε4基因型的患者.

关键词:

在 ApoEEE 中.基因多形态的多态化糖原合成酶激酶-3ββ的作用.调解分析调解分析轻度的认知障碍轻度的认知障碍 2型糖尿病是什么?

更多相关视频

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Barnes Maze Testing Strategies with Small and Large Rodent Models

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...